Poised to Deliver Breakthroughs in Oncology and CNS Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or call (859) 446-7386.
View Top Employees from Bexion PharmaceuticalsWebsite | http://www.bexionpharma.com |
Revenue | $2 million |
Employees | 29 (29 on RocketReach) |
Founded | 2006 |
Address | 632 Russel St, Covington, Kentucky 41011, US |
Phone | (859) 446-7386 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology, Drug Stores & Pharmacies, Biopharma, Retail, Pharmaceuticals, Health Care, Science and Engineering, Life Science, Pharmaceutical |
Web Rank | 8 Million |
Keywords | Bexion Pharmaceuticals, Bexion Pharmaceuticals, Inc. |
Competitors | Angiochem, Cancer Prevention Pharmaceuticals, Inc, FirstString Research , Inc., Patrys Limited, Precision Biologics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Bexion Pharmaceuticals employee's phone or email?
The Bexion Pharmaceuticals annual revenue was $2 million in 2024.
Joyce LaViscount is the CFO of Bexion Pharmaceuticals.
29 people are employed at Bexion Pharmaceuticals.
Bexion Pharmaceuticals is based in Covington, Kentucky.
The NAICS codes for Bexion Pharmaceuticals are [32541, 3254, 325, 32].
The SIC codes for Bexion Pharmaceuticals are [28, 283].